Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis (RESTORE-CF)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03375047 |
Recruitment Status : Unknown
Verified November 2020 by Translate Bio, Inc..
Recruitment status was: Recruiting
First Posted : December 15, 2017
Last Update Posted : November 16, 2020
|
Sponsor:
Translate Bio, Inc.
Information provided by (Responsible Party):
Translate Bio, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | October 2021 |
Estimated Study Completion Date : | December 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):